PCR Test Market: Current Analysis and Forecast (2022-2030)

The PCR (Polymerase Chain Reaction) test is a laboratory technique used to detect the presence of DNA or RNA (ribonucleic acid) of a specific pathogen, such as a virus or bacteria, in a patient's sample, such as blood, saliva, or nasal swab. The PCR test is one of the most accurate and reliable diagnostic tests for infectious diseases and is widely used for COVID-19 testing. The PCR test works by amplifying a small amount of DNA or RNA from the patient's sample into billions of copies, which can be easily detected and quantified. The rising prevalence of genetic disorders is among the major reasons for the market growth of the PCT test globally. For instance, The World Health Organization estimates that 10 people in 1000 are affected. This means that 70 to 80 million people worldwide live with one of these diseases.

PCR Test Market is expected to grow at a strong CAGR of 8% during the forecast period owing to the frequent product launches. For instance, in May 2022, Cipla announced the launch of its real-time COVID-19 RT-PCR test kit in India. The "RT-Direct" Multiplex COVID-19 RT-PCR Test Kit is manufactured in partnership with Genes2Me Pvt Ltd.

Based on type, the market is segmented into standard PCR, real-time PCR, digital PCR, and others. The real-time PCR segment acquired a major share in 2021. RT-PCR is one of the most widely used and preferred methods for COVID-19 testing. The PCR test market has experienced significant growth since the start of the COVID-19 pandemic, with demand for testing kits and related products increasing rapidly. Further, the RT PCR gives accurate results and provides real-time results which is also an important factor for the high share of segment in the PCR test market.

Based on the product, the market is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment held a prominent share in 2021. Reagents and consumables are essential components of the PCR test market, as they are necessary for conducting PCR tests and producing reliable results. PCR reagents include various enzymes, such as Taq polymerase and reverse transcriptase, as well as buffers, nucleotides, and other chemicals required for amplifying and detecting the genetic material of interest. These are the several reasons for dominating share of reagents & consumables in the PCR test market.

Based on the indication, the market is segmented into infectious diseases, oncology, and genetic disorders. The infectious diseases segment is expected to grow with the highest CAGR during the forecast period. The increasing incidences of infectious disorders are the major reason responsible for the growth of the segment in the PCR test market. For instance, as per the World Health Organization (WHO), 38.4 million people are living with HIV worldwide in 2021.

Based on the end-user, the market is segmented into hospitals & clinics, pharmaceuticals & biotechnology industries, diagnostics centers, and others. The diagnostics centers segment is expected to grow with the highest CAGR during the forecast period. The fast and accurate results offered by the diagnostic centers and the availability of at-home sample collection are the important factors responsible for the fast growth of diagnostics centers in the PCR test market.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America is a dominant region in the PCR test market. This is mainly due to the high prevalence of cancer disease, along with the presence of well-established market players and frequent product launches in the region attributes to the region's prominent share in the region's PCR test. For instance, in September 2022, BD and CerTest Biotec announced that their newly developed monkeypox virus molecular polymerase chain reaction (PCR) assay is commercially available worldwide, including in the United States.

Some of the major players operating in the market include: Abbott.; Agilent Technologies, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd.; QIAGEN; GenMark Diagnostics, Inc.; Thermo Fisher Scientific Inc.; General Electric; and Danaher.